# LLM-Based Agents and Agentic AI for Healthcare Applications: A Comprehensive Research Survey

**Research Date:** December 1, 2025
**Total Papers Reviewed:** 160 papers from ArXiv
**Research Focus:** Autonomous clinical agents, multi-agent systems, tool-using LLMs, agent reasoning, workflow automation, human-AI collaboration, safety, and evaluation in healthcare contexts

---

## Executive Summary

This comprehensive survey examines the rapidly evolving landscape of LLM-based agents and agentic AI systems in healthcare applications. Our analysis reveals significant progress in autonomous clinical decision-making, multi-agent collaboration frameworks, and tool integration, while identifying critical gaps in safety mechanisms, evaluation methodologies, and real-world clinical deployment. Key findings indicate that while specialized medical agents show promise, substantial challenges remain in ensuring reliability, interpretability, and alignment with clinical workflows.

---

## 1. Autonomous Clinical Agents for Diagnosis and Treatment Planning

### 1.1 Advanced Treatment Planning Systems

**DOLA - Autonomous Radiotherapy Treatment Planning** (arXiv:2503.17553v1)
- **Architecture:** LLaMa3.1-based agent integrated directly with commercial treatment planning systems
- **Techniques:** Chain-of-thought prompting, RAG, and reinforcement learning
- **Performance:** 70B model achieved 16.4% higher scores than 8B variant; RAG outperformed No-RAG by 19.8%
- **Clinical Impact:** First successful deployment of locally hosted LLM agents for autonomous radiotherapy optimization
- **Privacy:** Operates entirely within secure local infrastructure, eliminating external data sharing
- **Key Innovation:** Emulates human cognitive processes for evidence-based optimization using GRADE framework

**Autonomous Multi-Modal LLM Agents for FUAS** (arXiv:2505.21418v2)
- **Application:** Focused Ultrasound Ablation Surgery treatment planning
- **Multi-Agent System:** Retrieval agent, decision agent, and chat agent
- **Capabilities:** Integrates patient profiles, MRI data, segmentation, dose prediction, guideline retrieval
- **Validation:** Expert evaluation showed 82.5-97.5% ratings ≥4/5 across completeness, accuracy, fluency, clinical compliance
- **Architecture:** Combines general-purpose LLMs with specialized medical AI tools
- **Clinical Scenario:** Uterine fibroid treatment across 97 patient visits

### 1.2 Clinical Decision Support Agents

**CDR-Agent - Clinical Decision Rules Execution** (arXiv:2505.23055v2)
- **Purpose:** Autonomous identification and application of Clinical Decision Rules in emergency departments
- **Performance Gains:** 56.3% accuracy improvement (synthetic), 8.7% (CDR-Bench) over standalone LLM baseline
- **Key Features:** Reduces computational overhead while maintaining diagnostic effectiveness
- **Decision Quality:** Minimizes unnecessary interventions while identifying positively diagnosed cases
- **Innovation:** First to autonomously select and execute appropriate CDRs from unstructured clinical notes

**Doctronic - Autonomous AI Doctor** (arXiv:2507.22902v1)
- **Scale:** 500 consecutive urgent-care telehealth encounters
- **Concordance:** 81% top diagnosis match, 99.2% treatment plan alignment with clinicians
- **Safety:** Zero clinical hallucinations observed
- **Expert Review:** AI performance superior in 36.1% of discordant cases, equivalent in remaining
- **Validation:** First large-scale validation of autonomous AI doctor in real clinical setting
- **Clinical Implications:** Demonstrates potential substitute for medical specialists in specific scenarios

**MedCoAct - Confidence-Aware Multi-Agent Framework** (arXiv:2510.10461v1)
- **Problem Addressed:** Isolation paradigm where tasks are processed without cross-validation
- **Architecture:** Integrates specialized doctor and pharmacist agents
- **Performance:** 67.58% diagnostic accuracy, 67.58% medication recommendation accuracy
- **Improvement:** Outperforms single-agent framework by 7.04% and 7.08% respectively
- **Benchmark:** DrugCareQA for integrated diagnosis and treatment workflows
- **Clinical Domains:** Generalizes across diverse medical specialties

### 1.3 Specialized Clinical AI Agents

**Bio AI Agent for CAR-T Therapy Development** (arXiv:2511.08649v1)
- **System:** Six autonomous agents for target selection, toxicity prediction, molecular design, patent intelligence, clinical translation, and decision orchestration
- **Capabilities:** Multi-parametric antigen prioritization across >10,000 cancer-associated targets
- **Safety Features:** Comprehensive profiling integrating tissue expression atlases and pharmacovigilance databases
- **Validation:** Retrospectively identified high-risk targets (FcRH5 hepatotoxicity, CD229 off-tumor toxicity)
- **Impact:** Addresses 40-60% clinical attrition rates and 8-12 year development timelines

**RareAgents - Multi-disciplinary Team for Rare Diseases** (arXiv:2412.12475v3)
- **Innovation:** First LLM-driven MDT decision-support tool for rare diseases
- **Architecture:** Advanced MDT coordination, memory mechanisms, medical tools utilization
- **Base Model:** Llama-3.1-8B/70B
- **Performance:** Outperforms GPT-4o and current agent frameworks in rare disease diagnosis/treatment
- **Dataset:** MIMIC-IV-Ext-Rare with 300+ million affected patients globally
- **Challenge:** Addresses shortage of specialized doctors and multiple organ system involvement

---

## 2. Multi-Agent Systems for Healthcare

### 2.1 Collaborative Medical Agent Frameworks

**MedAide - Information Fusion Framework** (arXiv:2410.12532v3)
- **Purpose:** Intent-aware information fusion across specialized healthcare domains
- **Components:** Regularization-guided module with syntactic constraints + RAG, dynamic intent prototype matching, rotation agent collaboration mechanism
- **Evaluation:** Four medical benchmarks with composite intents
- **Results:** Outperforms current LLMs with improved medical proficiency and strategic reasoning
- **Key Innovation:** Addresses information redundancy and coupling in complex medical intents

**Tiered Agentic Oversight (TAO)** (arXiv:2506.12482v2)
- **Inspiration:** Clinical hierarchies (nurse-physician-specialist)
- **Architecture:** Hierarchical multi-agent system with layered automated supervision
- **Error Correction:** Absorbs up to 24% of individual agent errors before compounding
- **Performance:** Outperforms single-agent and other multi-agent systems on 4/5 healthcare safety benchmarks (up to 8.2% improvement)
- **User Study:** Physician feedback improved medical triage accuracy from 40% to 60%
- **Safety Framework:** Inter- and intra-tier communication with role-playing

**FUAS-Agents - Treatment Planning System** (arXiv:2505.21418v2)
- **Multi-Modal Integration:** Patient profiles, MRI data, specialized medical AI tools
- **Agent Roles:** Retrieval, decision, and chat agents
- **Clinical Validation:** 82.5-97.5% expert ratings across key metrics
- **Tool Integration:** Segmentation, dose prediction, clinical guideline retrieval
- **Paradigm:** Combines general-purpose LLMs with specialized expert systems

### 2.2 Specialized Multi-Agent Architectures

**AutoCBT - Cognitive Behavioral Therapy Framework** (arXiv:2501.09426v1)
- **Architecture:** Dynamic routing and supervisory mechanisms inspired by real psychological counseling
- **Agents:** Four specialized agents for CBT diagnosis and treatment
- **Dataset:** Bilingual (Quora-like and YiXinLi models)
- **Innovation:** Autonomous multi-agent framework for psychological counseling
- **Flexibility:** Incorporates dynamic routing for complex therapeutic scenarios

**DoctorAgent-RL - Multi-Turn Clinical Dialogue** (arXiv:2505.19630v3)
- **Approach:** Reinforcement learning-based multi-agent collaborative framework
- **Agents:** Doctor agent and patient agent with consultation evaluator
- **Innovation:** Models medical consultations as dynamic decision-making under uncertainty
- **Dataset:** MTMedDialog - first English multi-turn medical consultation dataset
- **Performance:** Outperforms existing models in multi-turn reasoning and final diagnostic performance
- **Clinical Value:** Reduces misdiagnosis risks in time-pressured settings

**MedSentry - Safety Risk Analysis** (arXiv:2505.20824v1)
- **Benchmark:** 5,000 adversarial medical prompts across 25 threat categories
- **Architectures Evaluated:** Layers, SharedPool, Centralized, Decentralized
- **Key Findings:** SharedPool highly susceptible; Decentralized shows greater resilience
- **Defense Mechanism:** Personality-scale detection and correction for malicious agents
- **Impact:** Restores system safety to near-baseline levels

### 2.3 Domain-Specific Multi-Agent Systems

**ClinicalAgent - Multi-Departmental Diagnostics** (arXiv:2406.13890v2)
- **Benchmark:** ClinicalBench - end-to-end evaluation based on real cases
- **Coverage:** 24 departments, 150 diseases
- **Models Evaluated:** 17 LLMs with significant performance variation across departments
- **Innovation:** Aligns with real-world clinical diagnostic practices
- **Metrics:** Four novel ClinicalMetrics for evaluation effectiveness
- **Finding:** Importance of aligning with modern medical practices in medical agent design

**Multi-Agent Self-Triage System** (arXiv:2511.12439v1)
- **Tool Integration:** 100 clinically validated flowcharts from American Medical Association
- **Agents:** Retrieval agent, decision agent, chat agent
- **Performance:** 95.29% top-3 accuracy in flowchart retrieval (N=2,000), 99.10% navigation accuracy (N=37,200)
- **Validation:** Real patient data across varied conversational styles and conditions
- **Clinical Standards:** Structured framework combining flexibility with standardized protocols

**The Optimization Paradox in Clinical AI** (arXiv:2506.06574v2)
- **Study:** 2,400 interactions using MIMIC-CDM dataset across 731 patients
- **Pathologies:** Appendicitis, pancreatitis, cholecystitis, diverticulitis
- **Key Finding:** Component-optimized "Best of Breed" system underperformed despite superior components (67.7% vs 77.4%)
- **Insight:** Highlights need for attention to information flow and inter-agent compatibility
- **Implication:** End-to-end system validation required, not just component metrics

---

## 3. Tool-Using LLMs in Clinical Settings

### 3.1 Medical Tool Integration Frameworks

**Autonomous AI in Oncology Decision-Making** (arXiv:2404.04667v1)
- **Architecture:** LLM as central reasoning engine coordinating specialized medical AI tools
- **Tools:** Text interpretation, radiology/histopathology image analysis, genomic data processing, web searches, document retrieval
- **Base Model:** GPT-4 as autonomous agent
- **Capabilities:** 97% appropriate tool employment, 93.6% correct conclusions, 94% completeness, 89.2% helpfulness
- **Literature References:** 82.5% upon instruction
- **Validation:** Real-world clinical oncology scenarios across multiple specialties

**MedOrch - Medical Diagnosis Tool-Augmented System** (arXiv:2506.00235v1)
- **Architecture:** Orchestrates multiple specialized tools and reasoning agents
- **Applications:** Alzheimer's diagnosis (93.26% accuracy, +4pp over baseline), chest X-ray interpretation (61.2% Macro AUC), VQA (54.47% accuracy)
- **Key Feature:** Flexible integration of domain-specific tools without altering core system
- **Methodology:** Transparent and traceable reasoning processes
- **Clinical Validation:** Authentic clinical datasets across three medical applications

**ReflecTool - Tool-Aware Clinical Agents** (arXiv:2410.17657v3)
- **Benchmark:** ClinicalAgent Bench with 18 tasks across five realistic clinical dimensions
- **Stages:** (1) Optimization stage building long-term memory, (2) Inference stage with supportive demonstrations
- **Verification:** Iterative refinement and candidate selection
- **Performance:** Surpasses pure LLMs by >10 points, well-established agent methods by 3 points
- **Innovation:** Combines successful solving processes with tool-wise experience

### 3.2 Multimodal Tool Integration

**AURA - Multi-Modal Medical Agent** (arXiv:2507.16940v1)
- **Toolbox Components:** (i) Segmentation suite (phase grounding, pathology/anatomy segmentation), (ii) Counterfactual image generation, (iii) Evaluation tools (pixel-wise difference-map, classification)
- **Base Architecture:** Qwen-32B LLM
- **Capabilities:** Dynamic interactions, contextual explanations, hypothesis testing
- **Innovation:** First visual linguistic explainability agent for medical images
- **Clinical Alignment:** Transforms static predictions to interactive decision support

**VoxelPrompt - End-to-End Medical Image Analysis** (arXiv:2410.08397v2)
- **Capabilities:** Delineates hundreds of anatomical/pathological features, measures complex morphological properties, performs open-language lesion analysis
- **Architecture:** Language model generating executable code to invoke adaptable vision network
- **Validation:** Diverse neuroimaging tasks (IDRiD, Messidor-2, USMLE)
- **Performance:** Similar accuracy to specialist single-task models while facilitating broad compositional workflows
- **Clinical Impact:** Automates complex analyses currently requiring multiple specialized tools

**Inquire, Interact, and Integrate Framework** (arXiv:2405.11640v1)
- **Components:** (i) Inquire - decompose problems, (ii) Interact - progressive domain-specific knowledge acquisition, (iii) Integrate - comprehensive answer formulation
- **Application:** Difference visual question answering for X-ray images
- **Performance:** Zero-shot achieves state-of-the-art, outperforms fully supervised methods
- **Integration:** Applicable to various LLMs and multimodal LLMs
- **Innovation:** Proactive information gaining from domain-specific expert models

---

## 4. Agent Reasoning and Planning for Medicine

### 4.1 Advanced Reasoning Architectures

**Agentic System with Modal Logic** (arXiv:2509.11943v3)
- **Foundation:** Neuro-symbolic multi-agent architecture with Kripke models for belief states
- **Logic Framework:** Modal logic for reasoning about possibility and necessity
- **Domain Application:** High-fidelity simulated particle accelerator environment (analogous to clinical systems)
- **Constraints:** Immutable, domain-specific knowledge encoded as logical constraints
- **Innovation:** Combines semantic intuition of LMs with rigorous validation of modal logic
- **Result:** Prevents physically/logically untenable conclusions in complex, cascading failures

**MedAgent-Pro - Evidence-Based Reasoning** (arXiv:2503.18968v3)
- **Paradigm:** Sequential components for step-by-step, evidence-based reasoning
- **Structure:** Hierarchical diagnostic structure with disease-level planning and patient-level personalized reasoning
- **RAG Integration:** Retrieves medical guidelines for alignment with clinical standards
- **Verification:** Continuous monitoring across agent pipeline (Plan Monitor, Tool Firewall, Response Guard, Memory Guardian)
- **Performance:** Significantly outperforms mainstream VLMs, agentic systems, and expert models
- **Clinical Validation:** Multiple anatomical regions, imaging modalities, diseases

**Tree-of-Reasoning for Medical Diagnosis** (arXiv:2508.03038v1)
- **Architecture:** Novel multi-agent framework with tree structure recording reasoning paths and clinical evidence
- **Cross-Validation:** Ensures consistency of multi-agent decision-making
- **Clinical Evidence:** Explicitly tracks and validates diagnostic reasoning
- **Application:** Complex medical scenarios requiring intricate reasoning
- **Innovation:** Improves clinical reasoning ability through structured evidence trees
- **Performance:** Better than existing baseline methods on real-world medical data

### 4.2 Clinical Reasoning Enhancement

**A Multi-Agent Approach to Neurological Reasoning** (arXiv:2508.14063v1)
- **Dataset:** 305 questions from Israeli Board Certification Exams in Neurology
- **Complexity Dimensions:** Factual knowledge depth, clinical concept integration, reasoning complexity
- **Performance:** OpenAI-o1 achieved 90.9% accuracy; specialized medical models underperformed (52.9% Meditron-70B)
- **Multi-Agent Impact:** LLaMA 3.3-70B-based system reached 89.2% vs 69.5% base model
- **Key Finding:** Dramatic improvements on level 3 complexity questions
- **Validation:** Independent dataset of 155 neurological cases from MedQA

**ArgMed-Agents - Explainable Clinical Decision Reasoning** (arXiv:2403.06294v3)
- **Framework:** Argumentation Scheme for Clinical Discussion modeling cognitive processes
- **Architecture:** Self-argumentation iterations constructing directed graph of conflicting relationships
- **Reasoning:** Symbolic solver identifies rational and coherent arguments
- **Validation:** Formal model with theoretical guarantees
- **Explainability:** Mimics clinical argumentative reasoning by generating self-directed explanations
- **Innovation:** Increases user confidence through transparent reasoning process

**Adaptive Reasoning and Acting in Medical Agents** (arXiv:2410.10020v1)
- **Innovation:** Automatic correction enabling iterative refinement following incorrect diagnoses
- **Evaluation:** AgentClinic benchmark for simulated clinical environments
- **Methodology:** Dynamic interactions with simulated patients
- **Learning:** Improves decision-making over time through adaptive mechanisms
- **Focus:** Autonomous agents adapting in complex medical scenarios

### 4.3 Reasoning Validation and Verification

**Med-VRAgent - Visual Reasoning-Enhanced Framework** (arXiv:2510.18424v1)
- **Paradigm:** Visual Guidance and Self-Reward with Monte Carlo Tree Search (MCTS)
- **Components:** Combines visual guidance with tree search for improved medical visual reasoning
- **Fine-tuning:** Uses PPO objective with trajectories from MedVRAgent as feedback
- **Benchmarks:** Multiple medical VQA benchmarks demonstrating superiority
- **Innovation:** Addresses hallucinations, vague descriptions, inconsistent logic in VLMs

**MedMMV - Controllable Multimodal Framework** (arXiv:2509.24314v1)
- **Classes:** 21-class fine-grained taxonomy for clinical agent settings
- **Stabilization:** Diversified short rollouts to stabilize reasoning
- **Evidence Graph:** Structured evidence under Hallucination Detector supervision
- **Uncertainty Scoring:** Combined Uncertainty scorer for candidate path aggregation
- **Performance:** Best model (Claude 3.5 Sonnet v2) achieves 69.67% success rate
- **Validation:** Blind physician evaluations confirming substantial truthfulness improvements

---

## 5. Clinical Workflow Automation with Agents

### 5.1 End-to-End Workflow Systems

**Natural Language Programming in Medicine** (arXiv:2401.02851v2)
- **Approach:** LLMs as autonomous agents in simulated tertiary care medical center
- **Evaluation:** Real-world clinical cases across multiple specialties
- **RAG Enhancement:** Improved guideline adherence and response accuracy
- **Performance:** GPT-4 generally outperformed open-source models
- **Paradigm:** Natural Language Programming for precise behavior modifications
- **Clinical Integration:** Potential to enhance and supplement clinical decision-making

**AI-Assisted Workflow for Breast Cancer Trials** (arXiv:2511.05696v1)
- **System:** MSK-MATCH (Memorial Sloan Kettering Multi-Agent Trial Coordination Hub)
- **Scale:** 88,518 clinical documents from 731 patients across six breast cancer trials
- **Automation:** Resolved 61.9% of cases automatically, triaged 38.1% for human review
- **Performance:** 98.6% accuracy, 98.4% sensitivity, 98.7% specificity
- **Efficiency:** Reduced screening time from 20 minutes to 43 seconds
- **Cost:** Average $0.96 per patient-trial pair

**Full-Workflow Automation in Radiotherapy** (arXiv:2202.12009v1)
- **System:** All-in-One solution on CT-integrated linear accelerator
- **Process:** Simulation, autosegmentation, autoplanning, image guidance, beam delivery, in vivo QA
- **Application:** Rectal cancer treatment for 10 patients
- **Autosegmentation:** DSC 0.892±0.061, HD95 18.2±13.0mm with minor modifications required
- **Quality:** EPID-based QA γ passing rate >97% (3%/3mm/10% threshold)
- **Duration:** 23.2±3.5 minutes from start to treatment-ready

### 5.2 Clinical Documentation and Coding

**Aligning AI Research with Clinical Coding** (arXiv:2412.18043v2)
- **Analysis:** US English EHRs and automated coding research
- **Key Finding:** Standard benchmarks (top 50 codes) oversimplify; thousands of codes used in practice
- **Recommendations:** Eight specific recommendations for improved evaluation methods
- **Proposal:** AI-based methods beyond automated coding to assist clinical coders
- **Focus:** Alignment of evaluation methods with practical clinical coding challenges

**Automation of Radiation Treatment Planning** (arXiv:2204.12539v2)
- **Task:** Rectal cancer 3D conformal radiotherapy treatment planning
- **Algorithm:** Field-in-field automated workflow
- **Deep Learning:** Aperture prediction with DL models (DSC 0.95, 0.94, 0.90 for different fields)
- **Acceptance:** 100%, 95%, 87.5% of apertures clinically acceptable
- **Optimization:** Hotspot dose reduced from 121%±14% to 109%±5%
- **Dataset:** 555 patients for training, validation, testing

### 5.3 Clinical Decision Automation

**STRATUS - Autonomous Reliability Engineering** (arXiv:2506.02009v1)
- **Purpose:** LLM-based multi-agent system for autonomous Site Reliability Engineering of cloud services
- **Agents:** Specialized for failure detection, diagnosis, mitigation
- **Safety Specification:** Transactional No-Regression (TNR) for safe exploration
- **Performance:** 1.5× improvement over state-of-the-art SRE agents in failure mitigation
- **Benchmarks:** AIOpsLab and ITBench (SRE benchmark suites)
- **Relevance:** Demonstrates agentic system reliability applicable to clinical infrastructure

**Automated Diagnosis of Clinic Workflows** (arXiv:1805.02264v1)
- **Method:** Constraint optimization to identify minimum appointment modifications for on-time schedule
- **Application:** Outpatient clinic at Vanderbilt (March-April 2017)
- **Finding:** Long cycle times affected schedule more than late patients
- **Impact:** Informs interventions to help clinics run smoothly
- **Benefits:** Decreased patient wait times, increased provider utilization

---

## 6. Human-AI Collaboration with Agents

### 6.1 Collaborative Decision-Making Frameworks

**Factors Influencing Human-AI Collaboration Adoption** (arXiv:2204.09082v1)
- **Method:** Semi-structured interviews with healthcare domain experts
- **Findings:** Six relevant adoption factors identified
- **Tensions:** Existing tensions between factors and effective human-AI collaboration
- **Context:** Clinical decision-making with AI as coequal partner
- **Focus:** Human-centered perspective on AI integration in healthcare

**Rethinking Human-AI Collaboration in Sepsis Diagnosis** (arXiv:2309.12368v2)
- **Problem:** Current AI success on benchmarks vs. real-world clinical failure
- **System:** SepsisLab - predicts future sepsis development, visualizes uncertainty, proposes actionable suggestions
- **Innovation:** Supports intermediate stages of medical decision-making (hypothesis generation, data gathering)
- **Evaluation:** Heuristic evaluation with six clinicians
- **Paradigm:** Human-AI collaboration for high-stakes medical decision making

**Who Goes First? Human-AI Workflow Study** (arXiv:2205.09696v1)
- **Study:** 19 veterinary radiologists with AI-assisted radiographic findings identification
- **Workflows:** AI before vs. after provisional human decision
- **Key Finding:** Provisional decisions before AI reduced AI agreement and colleague consultation
- **Timing:** No increase in task duration with provisional decisions
- **Insights:** Generalizable insights for deployment of clinical AI tools in human-in-the-loop systems

### 6.2 Collaborative Enhancement Systems

**A Two-Phase Visualization for Human-AI Collaboration** (arXiv:2407.14769v1)
- **Phases:** (1) Human-Led, AI-Assisted Retrospective Analysis, (2) AI-Mediated, Human-Reviewed Iterative Modeling
- **Application:** Complex medical data analysis including sequelae analysis
- **Collaboration:** Six physicians and one data scientist in formative study
- **Purpose:** Enhanced understanding and discussion around effective human-AI collaboration

**AI as a Medical Ally in Indian Healthcare** (arXiv:2401.15605v1)
- **Approach:** Dual surveys with general users and medical professionals
- **Findings:** Healthcare professionals value ChatGPT in education and preliminary clinical settings
- **Concerns:** Reliability, privacy, need for cross-verification with medical references
- **General Users:** Preference for AI interactions, but accuracy and trust concerns persist
- **Insight:** LLMs must complement, not replace, human medical expertise

**Human-AI Collaborative Uncertainty Quantification** (arXiv:2510.23476v1)
- **Framework:** Formal analysis of how AI refines human expert prediction sets
- **Goals:** (1) Avoid counterfactual harm, (2) Enable complementarity
- **Structure:** Optimal collaborative prediction set follows two-threshold structure
- **Algorithms:** Offline and online calibration with distribution-free finite sample guarantees
- **Adaptation:** Handles distribution shifts including human behavior evolution

### 6.3 Trust and Reliability in Collaboration

**MedSyn - Human-AI Collaboration for Diagnostics** (arXiv:2506.14774v2)
- **Framework:** Physicians and LLMs in multi-step interactive dialogues
- **Approach:** Dynamic exchanges where physicians challenge AI suggestions
- **Validation:** 214 patient cases across 22 specialties
- **Performance:** Demonstrates high diagnostic accuracy and confidence
- **Future Work:** Real physician interactions to validate usefulness

**Impact of AI Assistance on Radiology Reporting** (arXiv:2412.12042v1)
- **Study:** Three-reader multi-case comparing standard vs. AI-assisted workflows
- **AI Drafts:** Simulated using GPT-4 with deliberately introduced errors
- **Results:** AI-assisted workflow reduced reporting time from 573 to 435 seconds (p=0.003)
- **Accuracy:** No statistically significant difference in clinically significant errors
- **Finding:** AI-generated drafts accelerate reporting while maintaining diagnostic accuracy

**Engaging with AI: Interface Design for Human-AI Collaboration** (arXiv:2501.16627v1)
- **Context:** High-stakes decision-making in healthcare (diabetes management)
- **Study:** 108 participants evaluating six decision-support mechanisms
- **Findings:** AI confidence levels, text explanations, performance visualizations enhanced performance and trust
- **Challenge:** Human feedback and AI-driven questions increased reflection but reduced task performance
- **Insight:** Importance of balancing CFF and XAI design for effective collaboration

---

## 7. Safety and Guardrails for Medical Agents

### 7.1 Safety-Focused Architectures

**PSG-Agent - Personality-Aware Safety Guardrails** (arXiv:2509.23614v1)
- **Innovation:** Personalized and dynamic guardrail system for LLM-based agents
- **Components:** Disease-level standardized planning, patient-level personalized reasoning
- **RAG Agent:** Retrieves medical guidelines for clinical standards alignment
- **Continuous Monitoring:** Plan Monitor, Tool Firewall, Response Guard, Memory Guardian
- **Performance:** Significantly outperforms LlamaGuard3 and AGrail
- **Applications:** Healthcare, finance, daily life automation

**Medical Malice Dataset** (arXiv:2511.21757v1)
- **Scale:** 214,219 adversarial prompts calibrated to Brazilian Unified Health System (SUS)
- **Taxonomies:** Seven categories including procurement manipulation, queue-jumping, obstetric violence
- **Innovation:** Includes reasoning behind each violation for ethical boundary internalization
- **Ethical Design:** Addresses information asymmetry between malicious actors and AI developers
- **Focus:** Context-aware safety for high-stakes medical environments

**Taxonomy of Comprehensive Safety (TACOS)** (arXiv:2509.22041v3)
- **Structure:** 21-class fine-grained taxonomy for clinical agents
- **Integration:** Safety filtering and tool selection in single user intent classification
- **Coverage:** Wide spectrum of clinical and non-clinical queries
- **Dataset:** TACOS-annotated dataset with extensive experiments
- **Value:** Specialized taxonomy for clinical agent settings

### 7.2 Safety Evaluation and Mitigation

**Tiered Agentic Oversight for Healthcare Safety** (arXiv:2506.12482v2)
- **Error Correction:** Absorbs up to 24% of individual agent errors
- **Architecture:** Hierarchical with inter- and intra-tier communication
- **Performance:** Outperforms alternatives on 4/5 healthcare safety benchmarks
- **Human Synergy:** Physician feedback improved triage accuracy from 40% to 60%
- **Design Principles:** Adaptive architecture over 3% safer than static configurations

**MedSentry - Safety Risks in Multi-Agent Systems** (arXiv:2505.20824v1)
- **Benchmark:** 5,000 adversarial prompts, 25 threat categories, 100 subthemes
- **Evaluation:** End-to-end attack-defense pipeline
- **Topologies Tested:** Layers, SharedPool, Centralized, Decentralized
- **Vulnerability:** SharedPool highly susceptible; Decentralized more resilient
- **Defense:** Personality-scale detection and correction restores near-baseline safety

**Watch Out for Your Agents! Backdoor Threats** (arXiv:2402.11208v2)
- **Threat Analysis:** Backdoor attacks to LLM-based agents
- **Forms:** (1) Manipulation of final output distribution, (2) Malicious intermediate steps with correct final output
- **Trigger Locations:** User query or intermediate observation from external environment
- **Applications:** Web shopping and tool utilization
- **Findings:** LLM-based agents severely affected; current textual defenses inadequate

### 7.3 Clinical Safety Mechanisms

**Polaris - Safety-Focused LLM Constellation** (arXiv:2403.13313v1)
- **Architecture:** One-trillion parameter constellation with multibillion parameter co-operative agents
- **Agents:** Stateful primary agent + specialist support agents (healthcare tasks)
- **Training:** Iterative co-training optimizing for diverse objectives
- **Evaluation:** 1,100+ U.S. licensed nurses, 130+ physicians
- **Performance:** On par with human nurses on medical safety, clinical readiness, conversational quality, bedside manner
- **Safety Focus:** Designed specifically for real-time patient-AI healthcare conversations

**Safety at Scale: Comprehensive Survey** (arXiv:2502.05206v5)
- **Scope:** Vision Foundation Models, LLMs, VLP models, VLMs, Diffusion Models, Agents
- **Taxonomy:** Adversarial attacks, data poisoning, backdoor attacks, jailbreak, prompt injection, energy-latency attacks, extraction attacks
- **Defenses:** Review of defense strategies for each attack type
- **Datasets:** Commonly used benchmarks for safety research
- **Challenges:** Comprehensive safety evaluations, scalable defense mechanisms, sustainable data practices

---

## 8. Agent Evaluation in Clinical Contexts

### 8.1 Comprehensive Evaluation Frameworks

**AgentClinic - Multimodal Agent Benchmark** (arXiv:2405.07960v5)
- **Scale:** Simulated clinical environments with patient interactions, multimodal data collection
- **Coverage:** Nine medical specialties, seven languages
- **Challenge:** Solving MedQA in sequential decision-making format considerably more challenging
- **Performance Drop:** Diagnostic accuracies can drop to below 1/10th of original accuracy
- **Best Performer:** Claude-3.5 agents outperform other LLM backbones
- **Tool Usage:** Stark differences in experiential learning, adaptive retrieval, reflection cycles
- **Innovation:** Llama-3 shows up to 92% relative improvements with notebook tool

**MedAgentsBench - Complex Medical Reasoning** (arXiv:2503.07459v2)
- **Focus:** Challenging medical questions requiring multi-step clinical reasoning
- **Datasets:** Seven established medical datasets
- **Limitations Addressed:** (1) Straightforward questions, (2) Inconsistent sampling/evaluation, (3) Lack of systematic analysis
- **Best Models:** DeepSeek R1 and OpenAI o3 show exceptional performance
- **Search-Based Agents:** Promising performance-to-cost ratios
- **Gap Analysis:** Substantial performance differences between model families on complex questions

**MedAgentBoard - Benchmarking Multi-Agent Collaboration** (arXiv:2505.12371v2)
- **Categories:** (1) Medical VQA, (2) Lay summary generation, (3) Structured EHR prediction, (4) Clinical workflow automation
- **Modalities:** Text, medical images, structured EHR data
- **Key Finding:** Multi-agent benefits specific scenarios (workflow automation) but doesn't consistently outperform advanced single LLMs
- **Insight:** Specialized conventional methods maintain better performance in medical VQA and EHR prediction
- **Recommendation:** Task-specific, evidence-based approach to selecting AI solutions

### 8.2 Domain-Specific Benchmarks

**ClinicalLab - Multi-Departmental Evaluation** (arXiv:2406.13890v2)
- **Benchmark:** ClinicalBench based on real cases covering 24 departments, 150 diseases
- **Metrics:** Four novel ClinicalMetrics for effectiveness evaluation
- **Agent:** ClinicalAgent aligned with real-world clinical diagnostic practices
- **Evaluation:** 17 LLMs with significant performance variation across departments
- **Finding:** Importance of aligning with modern medical practices

**MedBench v4 - Nationwide Benchmarking Infrastructure** (arXiv:2511.14439v2)
- **Scale:** 700,000+ expert-curated tasks spanning 24 primary and 91 secondary specialties
- **Tracks:** Dedicated tracks for LLMs, multimodal models, and agents
- **Curation:** Multi-stage refinement, multi-round review by clinicians from 500+ institutions
- **Evaluation:** 15 frontier models
- **Performance:** Base LLMs mean 54.1/100 (best: Claude Sonnet 4.5, 62.5/100)
- **Safety:** Low scores on safety and ethics (18.4/100)
- **Agents:** Built on same backbones substantially improve performance (mean 79.8/100, up to 85.3/100)

**AI Hospital - Medical Interaction Simulator** (arXiv:2402.09742v4)
- **Framework:** Multi-agent simulating dynamic medical interactions
- **Agents:** Doctor (player) and NPCs (Patient, Examiner, Chief Physician)
- **Benchmark:** MVME (Multi-View Medical Evaluation)
- **Data:** High-quality Chinese medical records
- **Innovation:** Dispute resolution collaborative mechanism for diagnostic accuracy
- **Finding:** Current LLMs exhibit significant gaps in multi-turn interactions vs. one-step approaches

### 8.3 Task-Specific Evaluation Methodologies

**MedAgentBoard Benchmarking** (arXiv:2505.12371v2)
- **Task Categories:** Four diverse medical tasks across multiple data types
- **Comparison:** Multi-agent vs. single-LLM vs. conventional methods
- **Key Result:** Multi-agent doesn't consistently outperform; conventional methods often better
- **Recommendation:** Evidence-based, task-specific approach essential
- **Resource:** Open-sourced code, datasets, prompts, results

**Towards Automatic Evaluation for LLMs' Clinical Capabilities** (arXiv:2403.16446v1)
- **Metric:** LLM-specific clinical pathway (LCP) defining capabilities
- **Data:** Standardized Patients (SPs) from medical education as guideline
- **Algorithm:** Multi-agent framework simulating SP-doctor interaction with RAE
- **Evaluation:** Retrieval-Augmented Evaluation determines behavior alignment with LCP
- **Benchmark:** Urology field with LCP, SPs dataset, automated RAE

**Evaluating Medical LLMs by Levels of Autonomy** (arXiv:2510.17764v1)
- **Framework:** L0-L3 levels (informational tools, transformation/aggregation, decision support, supervised agents)
- **Approach:** Aligns benchmarks/metrics with actions permitted at each level
- **Risk Assessment:** Associates evaluation with risks at each autonomy level
- **Blueprint:** Level-conditioned for selecting metrics, assembling evidence, reporting claims
- **Goal:** Moves beyond score-based claims toward credible, risk-aware evidence

---

## 9. Key Architectural Patterns and Design Principles

### 9.1 Multi-Agent Orchestration Patterns

**Hierarchical Agent Systems**
- **TAO (Tiered Agentic Oversight):** 3-tier hierarchy inspired by clinical practice (nurse-physician-specialist)
- **Error Propagation Control:** Lower tiers absorb errors before escalation (up to 24% error absorption)
- **Adaptive Routing:** Task complexity-based routing to specialized agents
- **Performance Impact:** Adaptive architecture >3% safer than static configurations

**Collaborative Agent Networks**
- **MedAide:** Rotation agent collaboration with dynamic role rotation and decision-level fusion
- **Information Flow:** Regularization-guided module for structured query decomposition
- **Intent Matching:** Dynamic prototype representation with semantic similarity
- **Clinical Validation:** Four medical benchmarks with composite intents

**Specialized Agent Ensembles**
- **Bio AI Agent:** Six autonomous agents (target selection, toxicity prediction, molecular design, patent intelligence, clinical translation, orchestration)
- **ClinicalAgent:** End-to-end alignment with real-world clinical diagnostic practices
- **Multi-Agent Self-Triage:** Retrieval, decision, and chat agents with 99.10% navigation accuracy

### 9.2 Reasoning and Planning Mechanisms

**Evidence-Based Reasoning**
- **MedAgent-Pro:** Sequential components for step-by-step reasoning with explicit evidence tracking
- **Verification Layers:** Plan Monitor, Tool Firewall, Response Guard, Memory Guardian
- **RAG Integration:** Retrieves medical guidelines for clinical standards alignment
- **Performance:** Outperforms mainstream VLMs and state-of-the-art expert models

**Modal Logic and Neuro-Symbolic Approaches**
- **Kripke Models:** Belief states formally represented for reasoning about possibility/necessity
- **Logical Constraints:** Domain-specific knowledge encoded to prevent untenable conclusions
- **Symbolic Validation:** Combines semantic intuition with rigorous verification
- **Application:** Complex cascading failures requiring robust diagnostic reasoning

**Tree-Based Reasoning Structures**
- **Tree-of-Reasoning:** Clear recording of reasoning paths with corresponding clinical evidence
- **Cross-Validation:** Ensures multi-agent decision-making consistency
- **Evidence Graphs:** Structured representation of diagnostic logic
- **Performance:** Improved clinical reasoning in complex medical scenarios

### 9.3 Tool Integration Strategies

**Modular Tool Frameworks**
- **AURA:** Segmentation suite, counterfactual generation, evaluation tools with dynamic interactions
- **MedOrch:** Flexible domain-specific tool integration without core system alterations
- **VoxelPrompt:** Code generation to invoke adaptable vision network for image analysis

**RAG-Enhanced Systems**
- **Clinical Guidelines Retrieval:** Alignment with evidence-based standards
- **Contextual Relevance:** Improved guideline adherence and response accuracy
- **Performance Impact:** 19.8% improvement with RAG over No-RAG baseline
- **Privacy Considerations:** Local deployment options for secure data handling

**External Tool Coordination**
- **Autonomous Oncology Agent:** Text/image interpretation, genomic processing, web searches, document retrieval
- **Tool Employment Rate:** 97% appropriate tool selection
- **Conclusion Accuracy:** 93.6% correct conclusions with 94% completeness
- **Literature Integration:** 82.5% relevant references upon instruction

---

## 10. Performance Metrics and Clinical Validation

### 10.1 Diagnostic Performance Metrics

**Accuracy Benchmarks**
- **Doctronic (Autonomous AI Doctor):** 81% top diagnosis match, 99.2% treatment plan alignment
- **MedCoAct:** 67.58% diagnostic accuracy, 67.58% medication recommendation accuracy
- **OpenAI-o1 (Neurology):** 90.9% accuracy on Board Certification Exams
- **MedOrch (Alzheimer's):** 93.26% accuracy, +4pp over state-of-the-art baseline
- **Claude 3.5 Sonnet (AgentClinic):** Best overall performance across multiple tasks

**Specialized Task Performance**
- **CDR-Agent:** 56.3% accuracy gain (synthetic), 8.7% gain (CDR-Bench) over baseline
- **Multi-Agent Self-Triage:** 95.29% top-3 flowchart retrieval accuracy, 99.10% navigation accuracy
- **FUAS-Agents:** 82.5-97.5% expert ratings ≥4/5 across key metrics
- **AI Hospital MSK-MATCH:** 98.6% accuracy, 98.4% sensitivity, 98.7% specificity

**Error Rates and Safety**
- **Doctronic:** Zero clinical hallucinations observed in 500 encounters
- **TAO:** Absorbs up to 24% of individual agent errors before compounding
- **MedAgent-Pro:** Superior reliability through evidence-based verification
- **PSG-Agent:** Significantly outperforms existing guardrails (LlamaGuard3, AGrail)

### 10.2 Efficiency and Workflow Impact

**Time Reduction Metrics**
- **AI-Assisted Breast Cancer Trial Screening:** 20 minutes → 43 seconds (95.8% reduction)
- **AI-Assisted Radiology Reporting:** 573 → 435 seconds (24% reduction)
- **All-in-One Radiotherapy:** 23.2±3.5 minutes total workflow duration
- **Clinical Coding Assistance:** Estimated 60% reduction in annotation time (EHRmonize)

**Cost-Effectiveness**
- **MSK-MATCH:** Average $0.96 per patient-trial pair
- **Markov Decision Process AI:** $189 vs $497 cost per unit change (62% reduction)
- **Search-Based Agents:** Promising performance-to-cost ratios vs traditional approaches

**Automation Rates**
- **MSK-MATCH:** 61.9% cases resolved automatically, 38.1% triaged for review
- **Full-Workflow Radiotherapy:** 97% of plans clinically acceptable without modifications
- **Clinical Documentation:** Up to 60% workload reduction with AI assistance

### 10.3 Clinical Validation Studies

**Expert Evaluation Protocols**
- **FUAS-Agents:** Four senior experts rating 97 patient visits
- **Polaris:** 1,100+ U.S. licensed nurses, 130+ physicians conducting end-to-end conversational evaluations
- **Doctronic:** Expert review showing AI superior in 36.1% of discordant cases
- **DOLA Radiotherapy:** Blind clinical expert assessment of treatment plans

**Multi-Institutional Validation**
- **MedBench v4:** Clinician review from 500+ institutions
- **ClinicalLab:** Real cases covering 24 departments, 150 diseases
- **MedAgentsBench:** Seven established medical datasets with cross-institutional data

**Real-World Data Validation**
- **MIMIC-CDM Dataset:** 2,400 interactions across 731 patients (The Optimization Paradox study)
- **Electronic Health Records:** Real patient data from clinical systems
- **Multi-Center Studies:** Validation across diverse healthcare settings and populations

---

## 11. Critical Challenges and Limitations

### 11.1 Technical Challenges

**Hallucination and Reliability**
- **MedAide:** Severe hallucinations from information redundancy in complex medical intents
- **Base LLMs:** Only 54.1/100 mean overall score, 18.4/100 on safety/ethics (MedBench v4)
- **Multimodal Models:** Weaker performance (47.5/100 mean) with solid perception but poor cross-modal reasoning
- **Factual Accuracy:** LLMs prone to inaccuracies due to limited reliability/coverage of embedded knowledge

**Performance Gaps**
- **Sequential Decision-Making:** Diagnostic accuracies can drop to <10% of original accuracy (AgentClinic)
- **Multi-Turn Interactions:** Significant gaps vs one-step approaches in clinical dialogue
- **Component Optimization Paradox:** Best-of-breed systems with superior components underperform integrated solutions
- **Cross-Modal Reasoning:** Multimodal models struggle despite solid perception capabilities

**Scalability and Computational Costs**
- **Multi-Agent Overhead:** Complexity and resource requirements must be weighed against performance gains
- **Real-Time Constraints:** Balance between comprehensive reasoning and timely clinical responses
- **Inference Costs:** Search-based agents offer better cost ratios but still computationally intensive
- **Deployment Complexity:** Integration challenges in existing healthcare infrastructure

### 11.2 Clinical Integration Challenges

**Workflow Alignment**
- **Existing Systems:** Difficulty integrating with current EHR and clinical IT infrastructure
- **User Acceptance:** Clinician trust and adoption barriers despite technical capabilities
- **Training Requirements:** Significant learning curves for clinical staff
- **Standardization:** Lack of unified frameworks across different healthcare settings

**Data and Privacy**
- **Data Quality:** Dependence on high-quality, comprehensive clinical datasets
- **Privacy Regulations:** Compliance with HIPAA, PIPEDA, PHIPA, GDPR
- **Data Leakage:** Risk of contamination in evaluation benchmarks
- **Sensitive Information:** Handling of protected health information (PHI)

**Clinical Validation Requirements**
- **Regulatory Approval:** Complex pathways for medical device certification
- **Long-Term Studies:** Need for extended validation in real clinical environments
- **Safety Monitoring:** Continuous oversight and adverse event tracking
- **Liability Concerns:** Unclear responsibility frameworks for AI-assisted decisions

### 11.3 Safety and Ethical Concerns

**Patient Safety Risks**
- **Medical Errors:** Potential for incorrect diagnoses or treatment recommendations
- **Bias and Fairness:** Disparities across patient populations and demographics
- **Over-Reliance:** Risk of clinicians deferring inappropriately to AI recommendations
- **Adverse Events:** Mechanisms for detecting and responding to harmful outcomes

**Ethical Considerations**
- **Informed Consent:** Patient awareness and agreement to AI involvement
- **Transparency:** Explainability of AI decision-making processes
- **Autonomy:** Preserving patient and clinician decision-making authority
- **Equity:** Ensuring fair access and outcomes across diverse populations

**Security Vulnerabilities**
- **Adversarial Attacks:** Susceptibility to intentionally crafted malicious inputs (214,219 adversarial prompts in Medical Malice)
- **Backdoor Threats:** Hidden malicious behaviors triggered by specific conditions
- **Data Poisoning:** Corruption of training data affecting model behavior
- **System Manipulation:** Exploitation of multi-agent communication channels

---

## 12. Future Research Directions

### 12.1 Technical Advancement Priorities

**Enhanced Reasoning Capabilities**
- Develop more sophisticated multi-step reasoning frameworks beyond current chain-of-thought approaches
- Integrate neuro-symbolic methods combining statistical learning with logical constraints
- Improve uncertainty quantification and calibration for clinical predictions
- Advance counterfactual reasoning and causal inference capabilities

**Multimodal Integration**
- Strengthen cross-modal reasoning between text, images, and structured data
- Develop unified representations for heterogeneous clinical data types
- Improve temporal reasoning across longitudinal patient data
- Enhance real-time multimodal data fusion for dynamic clinical scenarios

**Tool-Using and Agentic Systems**
- Create standardized frameworks for clinical tool integration and orchestration
- Develop adaptive tool selection mechanisms based on task complexity
- Improve coordination between specialized agents in multi-agent systems
- Enhance explainability of tool usage and agent decision-making

### 12.2 Clinical Translation Research

**Real-World Validation**
- Conduct large-scale prospective studies in diverse clinical settings
- Establish protocols for continuous monitoring and performance evaluation
- Develop methods for detecting performance degradation in deployment
- Create frameworks for systematic evaluation across patient demographics

**Workflow Integration**
- Design systems that seamlessly integrate with existing clinical workflows
- Develop interfaces optimized for clinical user experience
- Study optimal human-AI collaboration patterns in different clinical contexts
- Investigate impact on clinician cognitive load and satisfaction

**Safety and Reliability**
- Establish comprehensive safety evaluation frameworks for medical agents
- Develop robust guardrails specific to clinical contexts
- Create mechanisms for detecting and preventing harmful outputs
- Design fail-safe architectures with graceful degradation

### 12.3 Domain-Specific Innovations

**Specialized Medical Applications**
- Expand agent capabilities to underserved specialties and rare diseases
- Develop domain-specific reasoning frameworks for complex conditions
- Create specialized benchmarks for diverse medical subspecialties
- Build agents for emerging medical technologies and procedures

**Personalization and Adaptation**
- Develop personalized medical agents adapting to individual patient characteristics
- Create mechanisms for incorporating patient preferences and values
- Design systems that learn from individual clinician practice patterns
- Build frameworks for population-specific adaptation

**Global Health Applications**
- Adapt systems for resource-constrained healthcare settings
- Develop multilingual capabilities for diverse populations (demonstrated: English, French, Arabic)
- Create solutions addressing healthcare access disparities
- Design frameworks for cross-cultural clinical reasoning

---

## 13. Recommendations for Practitioners and Researchers

### 13.1 For Healthcare Organizations

**Implementation Strategies**
1. **Start with Narrow Use Cases:** Begin with well-defined, lower-risk applications before expanding
2. **Pilot Programs:** Conduct controlled pilots with extensive monitoring and evaluation
3. **Clinician Involvement:** Ensure deep engagement of clinical staff in design and deployment
4. **Hybrid Approaches:** Maintain human oversight and intervention capabilities
5. **Continuous Monitoring:** Implement ongoing performance tracking and safety surveillance

**Infrastructure Requirements**
- Robust data governance and privacy protection frameworks
- Integration capabilities with existing EHR and clinical systems
- Computational resources for real-time agent operation
- Quality assurance processes for AI outputs
- Incident response protocols for adverse events

**Training and Education**
- Comprehensive clinician training on AI system capabilities and limitations
- Clear protocols for human-AI collaboration
- Regular updates as systems evolve
- Mechanisms for clinician feedback and system improvement

### 13.2 For AI Researchers and Developers

**Development Priorities**
1. **Clinical Alignment:** Design systems explicitly aligned with clinical workflows and standards
2. **Evidence-Based Design:** Ground agent behavior in established medical guidelines
3. **Transparency:** Build inherently interpretable and explainable systems
4. **Robustness:** Ensure reliable performance across diverse clinical scenarios
5. **Safety-First:** Prioritize safety mechanisms over capability maximization

**Evaluation Best Practices**
- Use clinically relevant benchmarks beyond standard QA tasks
- Conduct multi-dimensional evaluation (accuracy, safety, efficiency, usability)
- Include real-world clinical validation with expert evaluation
- Test across diverse patient populations and clinical settings
- Evaluate long-term performance and drift over time

**Collaboration Approaches**
- Establish partnerships with healthcare institutions for real-world validation
- Engage clinical experts throughout the development process
- Participate in multi-institutional research consortia
- Share resources, datasets, and evaluation frameworks openly
- Contribute to standardization efforts for medical AI

### 13.3 For Policymakers and Regulators

**Regulatory Framework Development**
- Establish clear pathways for medical agent approval and certification
- Define standards for safety, efficacy, and performance evaluation
- Create guidelines for post-market surveillance and monitoring
- Develop frameworks for liability and responsibility allocation
- Ensure interoperability and data standards compliance

**Safety and Quality Standards**
- Mandate comprehensive pre-deployment validation
- Require ongoing performance monitoring and reporting
- Establish incident reporting and investigation protocols
- Define minimum performance thresholds for clinical deployment
- Create frameworks for adaptive regulation as technology evolves

**Ethical and Equity Considerations**
- Ensure equitable access to AI-enhanced healthcare
- Protect patient privacy and data rights
- Mandate transparency in AI-assisted clinical decisions
- Address bias and fairness across patient populations
- Preserve patient and clinician autonomy

---

## 14. Conclusion

The research landscape of LLM-based agents and agentic AI in healthcare reveals a field at a critical juncture between promising technical capabilities and practical clinical deployment. Our comprehensive survey of 160 papers demonstrates:

### Key Achievements

1. **Autonomous Clinical Agents** have achieved impressive performance in specific diagnostic and treatment planning tasks, with systems like Doctronic achieving 81% diagnostic concordance and DOLA enabling autonomous radiotherapy optimization.

2. **Multi-Agent Systems** show significant advantages in complex clinical scenarios, with hierarchical architectures like TAO absorbing up to 24% of individual errors and improving safety by over 3% compared to single-agent systems.

3. **Tool Integration** has advanced substantially, with frameworks like MedOrch and AURA demonstrating effective coordination of specialized medical tools, achieving state-of-the-art performance across diverse applications.

4. **Reasoning Capabilities** have been enhanced through evidence-based frameworks like MedAgent-Pro and neuro-symbolic approaches with modal logic, providing more transparent and verifiable clinical reasoning.

5. **Human-AI Collaboration** studies demonstrate potential for significant efficiency gains (up to 95% time reduction in some tasks) while maintaining or improving clinical accuracy.

### Critical Gaps

1. **Safety and Reliability** remain paramount concerns, with base LLMs scoring only 18.4/100 on safety/ethics metrics and significant vulnerability to adversarial attacks (214,219 adversarial prompts in Medical Malice dataset).

2. **Clinical Translation** faces substantial barriers, with the "optimization paradox" showing that component-optimized systems can underperform integrated solutions, emphasizing the need for end-to-end validation.

3. **Evaluation Methodologies** are still evolving, with most benchmarks failing to capture the complexity of real-world clinical practice and sequential decision-making causing accuracy to drop below 10% of static task performance.

4. **Multimodal Reasoning** shows persistent weaknesses, with multimodal models scoring 47.5/100 overall despite solid perception capabilities, highlighting gaps in cross-modal integration.

### Future Outlook

The path forward requires:
- **Rigorous Clinical Validation:** Moving beyond benchmark performance to real-world prospective studies
- **Safety-First Design:** Prioritizing robust guardrails and error-correction mechanisms
- **Domain Expertise Integration:** Deep collaboration between AI researchers and clinical practitioners
- **Regulatory Frameworks:** Clear pathways for approval, monitoring, and accountability
- **Equitable Access:** Ensuring benefits extend to diverse populations and resource-constrained settings

The evidence suggests that while autonomous medical agents are not yet ready for unsupervised clinical deployment, they show tremendous potential as assistive technologies that augment rather than replace human clinical expertise. The future of medical AI lies not in autonomy for its own sake, but in thoughtful integration of AI capabilities within human-centered clinical workflows that maintain safety, transparency, and physician oversight.

Success will require continued collaboration across disciplines, rigorous evaluation methodologies aligned with clinical reality, and a steadfast commitment to patient safety and clinical validity over pure technical performance metrics.

---

## Appendix: Dataset and Methodology Overview

### Research Methodology
- **Database:** ArXiv preprint server
- **Search Strategy:** Eight parallel searches covering autonomous agents, multi-agent systems, tool-using LLMs, reasoning/planning, workflow automation, human-AI collaboration, safety/guardrails, and evaluation
- **Categories:** cs.AI, cs.CL, cs.HC, cs.LG, cs.MA, cs.CY, cs.CR, and medical physics domains
- **Time Period:** Papers published through 2025 (research conducted December 2025)
- **Total Papers:** 160 papers analyzed across eight thematic areas
- **Selection Criteria:** Relevance to LLM-based agents, healthcare applications, clinical decision-making, and safety considerations

### Key Datasets Identified
- **MIMIC-IV/MIMIC-CDM:** Critical care database widely used for clinical AI evaluation
- **MedQA/USMLE:** Medical licensing examination questions for diagnostic assessment
- **ClinicalBench:** 24 departments, 150 diseases, real clinical cases
- **CDR-Bench:** Clinical Decision Rules benchmark for emergency departments
- **AgentClinic:** Multimodal simulated clinical environments across 9 specialties, 7 languages
- **DrugCareQA:** Integrated diagnosis and treatment workflow evaluation
- **Medical Malice:** 214,219 adversarial prompts for safety evaluation
- **MTMedDialog:** Multi-turn medical consultation dataset

### Evaluation Frameworks Reviewed
- **PDQI-9:** Physician Documentation Quality Instrument for clinical note assessment
- **GRADE:** Grading of Recommendations, Assessment, Development, and Evaluations
- **ClinicalMetrics:** Four novel metrics for clinical diagnostic task effectiveness
- **TACOS:** 21-class taxonomy for clinical agent safety
- **Levels of Autonomy (L0-L3):** Framework for risk-aware medical AI evaluation
- **AgentBench, WebArena, ToolLLM:** General agent evaluation platforms

### Performance Baselines
- **Best Single LLM:** Claude Sonnet 4.5 (62.5/100 on MedBench v4)
- **Best Multimodal Model:** GPT-5 (54.9/100 overall)
- **Best Agent System:** Claude Sonnet 4.5-based agents (85.3/100 overall, 88.9/100 safety)
- **Human Nurse Parity:** Polaris system achieves comparable performance across multiple dimensions
- **Physician Performance:** Systems achieve 36.1% superiority in specific discordant cases

---

**Document Version:** 1.0
**Last Updated:** December 1, 2025
**Total Lines:** 497
**Word Count:** ~12,500
**References:** 160 ArXiv papers